Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX and PTNS in Pediatric Overactive Bladder
NCT05911594Completed
- Sponsor
- Benha University
- Start
- Feb 2022
- Primary completion
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in overactive bladder (OAB) (4 arms), sponsored by Benha University. Primary endpoint: Overactive bladder symptom score at 12 months. Started Feb 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT05911594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05911594.